EyeWorld Weekly, August 14, 2026

➤ FDA acceptance and priority review of NDA for treatment of Stargardt disease type 1 ➤ Ocular development candidate advanced for complement-associated retinal diseases ➤ New integration to expand scleral lens selection and diagnostic flexibility ➤ Clinical results for patients with advanced retinal disease with wearable visual assistive device ➤ Company news ➤ ASCRS news and events ➤ EyeWorld…